New

Middle East and Africa Ocular Drug Delivery Market

2021

Pharmaceuticals Middle East and Africa Ocular Drug ...

Middle East and Africa Ocular Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, and Others), Formulation Type (Liposomes and Nanoparticles, Solution, Emulsion, Suspension, and Ointment), Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, and Others), and End User (Hospitals, Ophthalmic Clinics, and Ambulatory Surgical Centers)

Publication Month: Nov 2021 | Report Code: TIPRE00025782 | No. of Pages: 135 | Category: Pharmaceuticals | Status: Published

Market Insights

Middle East and Africa Ocular Drug Delivery Market to Grow at a CAGR of 6.3% to reach US$ 830.88 million Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The ocular drug delivery market in Middle East & Africa is expected to grow to US$ 830.88 million by 2028 from US$ 1,272.46 million in 2021. The market is estimated to grow at a CAGR of 6.3% from 2021 to 2028.


Several players operating in the ocular drug delivery market are developing and launching innovative products. The strategy of development and launch of new products helps companies to cater to a broad customer base. For instance, in June 2020, Senju Pharmaceutical Co., Ltd. and Otsuka Pharmaceutical Co., Ltd. announced the launch of a new combination ophthalmic solution, AILAMIDE Combination Ophthalmic Suspension, for the treatment of glaucoma and ocular hypertension. Additionally, in May 2019, Menicon Co., Ltd launched Menicon Bloom Myopia Control Management System. Menicon Bloom Night therapy includes the overnight wearing of a specifically designed reverse geometry orthokeratology contact lens—manufactured in hyper oxygen-permeable Menicon Z rigid material that guarantees ideal corneal oxygenation for comfortable contact lens wear. Such developments and launches of new products are emerging as a key trend in the ocular drug delivery market.

The COVID-19 pandemic has become the most significant challenge in the region. Middle East countries have been registered a growth in the number of COVID cases. Many countries in the region have less developed and underfunded health systems. Apart from this, a huge population already face a growing burden of non-communicable diseases, making them more vulnerable to the virus. However, in view of the 'social distancing' requirements, many conferences across the globe have been cancelled or postponed. One of the largest ophthalmic conferences, the World Ophthalmic Congress, which was supposed to be held in Cape Town, South Africa has gone completely online with a virtual conference. These factors are expected to negatively impact the growth of the ocular drug delivery market in the region for short terms. However, as the vaccination progresses, and pandemic situation is under control the region will offer several growth prospects for the market player in ocular drug delivery market.

With the new features and technologies, companies can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the ocular drug delivery market. The Middle East & Africa ocular drug delivery market is expected to grow at a good CAGR during the forecast period.

Get more information on this report :


Middle East & Africa Ocular Drug Delivery Market Segmentation

Middle East & Africa Ocular Drug Delivery Market – By Technology

  • Implantable Ocular Drug Delivery Systems
  • Particulate Drug Delivery Systems
  • Nano-Particle Drug Delivery System
  • Others

Middle East & Africa Ocular Drug Delivery Market – By Formulation Type

  • Solution
  • Ointment
  • Suspension
  • Emulsion
  • Liposomes and Nanoparticles

Middle East & Africa Ocular Drug Delivery Market – By Disease type

  • Cataract
  • Dry Eye Syndrome
  • Macular Degeneration
  • Glaucoma
  • Diabetic Retinopathy
  • Diabetic Macular Edema
  • Others

Middle East & Africa Ocular Drug Delivery Market – By End User

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers

Middle East & Africa Ocular Drug Delivery Market – By Country

  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • Canada
  • Mexico

Middle East & Africa Ocular Drug Delivery Market – Companies Mentioned

  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Novartis AG
  • Clearside Biomedical, Inc
  • Alimera Sciences, Inc.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Middle East & Africa Ocular Drug Delivery Market – By Technology

1.3.2 Middle East & Africa Ocular Drug Delivery Market – By Formulation Type

1.3.3 Middle East & Africa Ocular Drug Delivery Market – By Disease Type

1.3.4 Middle East & Africa Ocular Drug Delivery Market – By End User

1.3.5 Middle East & Africa Ocular Drug Delivery Market – By Country

2. Middle East & Africa Ocular Drug Delivery Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Ocular Drug Delivery Market – Market Landscape

4.1 Overview

4.2 Expert Opinions

5. Middle East & Africa Ocular Drug Delivery Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Accelerated Research on Ocular Drug Delivery

5.2 Market Restraints

5.2.1 Side Effects Associated with Ocular Drug Delivery

5.3 Market Opportunities

5.3.1 Growing Awareness About Vision Care

5.4 Future Trends

5.4.1 Emergence of Innovative Products

5.5 Impact analysis

6. Middle East & Africa Ocular Drug Delivery – Market Analysis

6.1 Middle East & Africa Ocular Drug Delivery Market Revenue Forecast and Analysis

7. Middle East & Africa Ocular Drug Delivery Market Analysis – By Technology

7.1 Overview

7.2 Middle East & Africa Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

7.3 Implantable Ocular Drug Delivery Systems

7.3.1 Overview

7.3.2 Implantable Ocular Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.4 Particulate Drug Delivery Systems

7.4.1 Overview

7.4.2 Particulate Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.5 Nano-Particle Drug Delivery System

7.5.1 Overview

7.5.2 Nano-Particle Drug Delivery System Market Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. Middle East & Africa Ocular Drug Delivery Market Analysis – By Formulation Type

8.1 Overview

8.1.1 Middle East & Africa Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

8.2 Liposomes and Nanoparticles Market

8.2.1 Overview

8.2.2 Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

8.3 Solution

8.3.1 Overview

8.3.2 Solution Market Revenue and Forecasts to 2028 (US$ Million)

8.4 Emulsion

8.4.1 Overview

8.4.2 Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

8.5 Suspension

8.5.1 Overview

8.5.2 Suspension Market Revenue and Forecasts to 2028 (US$ Million)

8.6 Ointment

8.6.1 Overview

8.6.2 Ointment Market Revenue and Forecasts to 2028 (US$ Million)

9. Middle East & Africa Ocular Drug Delivery Market Analysis – By Disease Type

9.1 Overview

9.2 Middle East & Africa Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

9.3 Cataract

9.3.1 Overview

9.3.2 Cataract Market Revenue and Forecast to 2028 (US$ Million)

9.4 Dry Eye Syndrome

9.4.1 Overview

9.4.2 Dry Eye Syndrome Market Revenue and Forecast to 2028 (US$ Million)

9.5 Macular Degeneration

9.5.1 Overview

9.5.2 Macular Degeneration Market Revenue and Forecast to 2028 (US$ Million)

9.6 Glaucoma

9.6.1 Overview

9.6.2 Glaucoma Market Revenue and Forecast to 2028 (US$ Million)

9.7 Diabetic Retinopathy

9.7.1 Overview

9.7.2 Diabetic Retinopathy Market Revenue and Forecast to 2028 (US$ Million)

9.8 Diabetic Macular Edema

9.8.1 Overview

9.8.2 Diabetic Macular Edema Market Revenue and Forecast to 2028 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)

10. Middle East & Africa Ocular Drug Delivery Market Analysis – By End User

10.1 Overview

10.2 Middle East & Africa Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.4 Ophthalmic Clinics

10.4.1 Overview

10.4.2 Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.5 Ambulatory Surgical Centers

10.5.1 Overview

10.5.2 Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

11. Middle East & Africa Ocular Drug Delivery Market – Country Analysis

11.1 Middle East & Africa Ocular Drug Delivery Market

11.1.1 Middle East and Africa: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)

11.1.1.1 Saudi Arabia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.1 Saudi Arabia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.2 Saudi Arabia: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3 Saudi Arabia: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.4 Saudi Arabia: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.5 Saudi Arabia: Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2 UAE: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.1 UAE: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.2 UAE: Ocular Drug Delivery Market , by Technology – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3 UAE: Ocular Drug Delivery Market , by Formulation Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.4 UAE: Ocular Drug Delivery Market, by Disease Type– Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.5 UAE: Ocular Drug Delivery Market , by End User – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3 South Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.1 South Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.2 South Africa: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3 South Africa: Ocular Drug Delivery Market , by Formulation Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.4 South Africa: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.5 South Africa: Ocular Drug Delivery Market, by End user– Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.6 Rest of Middle East and Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.7 Rest of Middle East and Africa: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.8 Rest of Middle East and Africa: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.9 Rest of Middle East and Africa: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.10 Rest of Middle East and Africa: Ocular Drug Delivery Market , by End User– Revenue and Forecast to 2028 (US$ Million)

12. Impact Of COVID-19 Pandemic on Middle East & Africa Ocular Drug Delivery Market

12.1 Impact Assessment of COVID-19 Pandemic

13. Industry Landscape

13.1 Overview

13.2 Organic Developments

13.2.1 Overview

13.3 Inorganic Developments

13.3.1 Overview

14. Company Profiles

14.1 AbbVie Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Bausch Health Companies Inc.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Alimera Sciences, Inc.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Novartis AG

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Clearside Biomedical, Inc.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. Saudi Arabia: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 2. Saudi Arabia: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Million)

Table 3. Saudi Arabia: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 4. Saudi Arabia: Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5. UAE: Ocular Drug Delivery Market , by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 6. UAE: Ocular Drug Delivery Market , by Formulation Type – Revenue and Forecast to 2028 (US$ Million)

Table 7. UAE: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 8. UAE: Ocular Drug Delivery Market , by End User – Revenue and Forecast to 2028 (US$ Million)

Table 9. South Africa: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 10. South Africa: Ocular Drug Delivery Market , by Formulation Type – Revenue and Forecast to 2028 (US$ Million)

Table 11. South Africa: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 12. South Africa: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 13. Rest of Middle East and Africa: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 14. Rest of Middle East and Africa: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Million)

Table 15. Rest of Middle East and Africa: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 16. Rest of Middle East and Africa: Ocular Drug Delivery Market , by End User– Revenue and Forecast to 2028 (US$ Million)

Table 17. Organic Developments Done By Companies

Table 18. Inorganic Developments Done by Companies

Table 19. Glossary of Terms, Ocular Drug Delivery Market

LIST OF FIGURES

Figure 1. Middle East & Africa Ocular Drug Delivery Market Segmentation

Figure 2. Middle East & Africa Ocular Drug Delivery Market Segmentation, By Country

Figure 3. Middle East & Africa Ocular Drug Delivery Market Overview

Figure 4. Implantable Ocular Drug Delivery Systems Segment Held the Largest Share of the Technology Segment in Ocular Drug Delivery Market

Figure 5. Saudi Arabia to Show Significant Growth During Forecast Period

Figure 6. Middle East & Africa Ocular Drug Delivery Market, Industry Landscape

Figure 7. Middle East & Africa PEST Analysis

Figure 8. Middle East & Africa Ocular Drug Delivery Market Impact Analysis of Driver and Restraints

Figure 9. Middle East & Africa Ocular Drug Delivery Market – Revenue Forecast and Analysis – 2021- 2028

Figure 10. Middle East & Africa Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

Figure 11. Implantable Ocular Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Particulate Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Nano-Particle Drug Delivery System Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. Middle East & Africa Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

Figure 16. Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Solution Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Suspension Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Ointment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Middle East & Africa Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

Figure 22. Cataract Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Dry Eye Syndrome Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Macular Degeneration Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Glaucoma Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Diabetic Retinopathy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Diabetic Macular Edema Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29. Middle East & Africa Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

Figure 30. Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 32. Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 33. Middle East & Africa: Ocular Drug Delivery Market, by Key Country – Revenue (2021) (US$ Million)

Figure 34. Middle East and Africa: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)

Figure 35. Saudi Arabia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. UAE: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. South Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38. Rest of Middle East and Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets

  1. AbbVie Inc.                                              
  2. Bausch Health Companies Inc.            
  3. Novartis AG                                            
  4. Clearside Biomedical, Inc                       
  5. Alimera Sciences, Inc.                          
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa ocular drug delivery market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the ocular drug delivery market as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution 
TIPRE00025782
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.
Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
© Copyright 2021 - The Insight Partners. All rights reserved